Lura Health of Newark announces business partnership with SCO Group to advance intraoral health monitoring

Health-tech company Lura Health announced Aug. 5 that it has entered into an investment and business partnership with Japanese med-tech company SCO Group, which is prominent in Japan’s dental technology sector, to deploy Lura Health’s intraoral sensor technology into clinical use in Asia.

Lura Health is developing wearable microsensors that can be worn inside the mouth, either attached to dental appliances or bonded directly to a tooth, to collect real-time biometric data such as pH levels and metabolites in saliva. The company is pioneering a health-care model that aims to “visualize whole-body health from within the oral cavity.”

Lura Health has created a continuous intraoral salivary monitoring sensor and is targeting medical device approval from the U.S. Food and Drug Administration by early 2027. Following regulatory approval, Lura plans to expand its reach into Asian markets, starting with Japan.

SCO Group is the operator of “Pay Light X,” an integrated dental clinic management platform in Japan that supports appointment booking, diagnosis, payment, and aftercare. By integrating its sensor technology with SCO Group’s clinical infrastructure, Lura Health aims to establish a new model for preventive health care in Japan. 

Future use cases for the technology extend into sports performance monitoring, eldercare, and wellness, positioning Lura’s sensors as a core tool in comprehensive personal health management.

“This collaboration represents a major step forward in our mission to enable preventive and user-friendly health monitoring through the diagnostic power of saliva,” said Daniel Weinstein, CEO of Lura Health. “Our vision aligns deeply with SCO Group’s commitment to improving the well-being of individuals through technology. Together, we will combine our sensor innovations with their extensive healthcare network to create tangible societal impact. We look forward to deploying our sensors in real-world clinical settings and co-developing patient-centered products based on live feedback from users in Japan.”

Yusuke Tamai, chairman and CEO of SCO Group, said “At SCO Group, we have long championed the integration of health technology into daily life, and this partnership allows us to take that mission to the next level. The oral cavity is a gateway to the body’s health, yet remains one of the least-monitored areas. By utilizing saliva — a highly accessible source of biological data — we aim to convert invisible health risks into visible insights. Combined with our Pay Light X platform, we intend to build a comprehensive preventive care model that spans diagnosis, treatment, and everyday living.”